from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1186c/-

LFCtreatmentdescriptionclass of inhibitor

-0.531

Amikacinug/mL Amikacintranslation

-0.832

Cap5-10ug/mL Capreomycintranslation

-1.360

Rox10-50 ug/mL Roxithromycintranslation

-0.298

SM2-5 ug/mL Streptomycintranslation

-1.667

Tet5-10 ug/mL Tetracyclinetranslation

-0.017

Rif0.2-5ug/mL Rifampicintranscription

1.066

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.325

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.413

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.167

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.346

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.865

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.602

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.491

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.762

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.734

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.736

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.090

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.565

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.966

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.520

KCN5-20 ug/mL Potassium cyaniderespiration

-0.660

NaN30.2-2 mM Sodium aziderespiration

-0.311

Nigericin50 uM Nigericinrespiration

0.265

TRC10-150 ug/mL Triclosanrespiration

0.499

TRZ10-25 ug/mL Thioridazinerespiration

0.038

Valinomycin0.5-10 uM Valinomycinrespiration

-1.953

ZnSO42 mM ZnSO4respiration

0.091

menadione6-10 ug/mL Menadionerespiration

-0.623

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.435

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.311

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.952

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.877

NRP_1Non-replicating persistence stage 1dosRassociated

0.195

Amp0.2mg/mL AmpicillincellWall

-0.619

Cephalexin20-100 ug/mL CephalexincellWall

-0.264

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.494

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.269

EMB10-20 ug/mL EthambutolcellWall

-0.870

Eta12-40 ug/mL EthionamidecellWall

-1.075

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.030

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.348

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.702

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.423

BZA0.12 mg/mL BenzamidearomaticAmides

0.929

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.597

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.248

H2O24 mM hydrogen peroxideDNAdamaging

-0.058

Levo10 ug/mL LevofloxacinDNAdamaging

0.704

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.082

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.130

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.056

UVUV-irradiationDNAdamaging

0.505

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.076

Antimycin12.5-50 ug/mL Antimycin A?

-0.110

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.263

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.374

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.558

PA8240.2-2 ug/mL PA-824?

-0.536

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.686

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.174

Verapamil50 uM Verapamil?

0.318

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.213

methoxatin10-20 ug/mL Methoxatin?